The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

Page 48 of 104

Advancing Alzheimer’s Disease treatment

The 2018 Clinical Trials on Alzheimer’s Disease (CTAD) conference showcased recent successes and failures in trials of Alzheimer’s disease treatments. Article B. Vellas (CTAD)    

Maximum walking speed

This study investigates the diagnostic accuracy of the combination of usual walking speed (UWS) and maximum walking speed (MWS) to identify frailty in community-dwelling older adults. (1) M. do Carmo Correia de Lima, T. Loffredo Bilton, W. Jefferson de Sousa… Continue Reading →

Designing trials of disease modifying agents for early and preclinical Alzheimer’s Disease intervention: What evidence is meaningful to patients, providers, and payers?

Background: Drug development for disease modifying agents in Alzheimer’s disease (AD) is focused increasingly on targeting underlying pathology in very early stages of AD or in cognitively normal patients at elevated risk of developing dementia due to Alzheimer’s. Very early… Continue Reading →

« Older posts Newer posts »

© 2026 Aging-news